Similar articles

• Group A streptococcal M proteins: virulence factors and protective antigens.

  Robinson JH, Kehoe MA. Robinson JH, et al. Immunol Today. 1992 Sep;13(9):362-7. doi: 10.1016/0167-5699(92)90173-5. Immunol Today. 1992. PMID: 1281632 Review.
• Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.

  Whitnack E, Dale JB, Beachey EH. Whitnack E, et al. Trans Assoc Am Physicians. 1983;96:197-202. Trans Assoc Am Physicians. 1983. PMID: 6208666 No abstract available.
• Recombinant tetravalent group A streptococcal M protein vaccine.

  Dale JB, Chiang EY, Lederer JW. Dale JB, et al. J Immunol. 1993 Aug 15;151(4):2188-94. J Immunol. 1993. PMID: 8345202
• Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.

  Kraus W, Haanes-Fritz E, Cleary PP, Seyer JM, Dale JB, Beachey EH. Kraus W, et al. J Immunol. 1987 Nov 1;139(9):3084-90. J Immunol. 1987. PMID: 2444650
• [Mechanisms and manifestations of population variability in Streptococcus pyogenes].

  Kaminskiĭ GD, Beliakov VD. Kaminskiĭ GD, et al. Vestn Akad Med Nauk SSSR. 1986;(7):10-7. Vestn Akad Med Nauk SSSR. 1986. PMID: 2428180 Review. Russian. No abstract available.